Literature DB >> 22945452

Surgical management of early cervical cancer: the shape of future studies.

Stefano Greggi1, Cono Scaffa.   

Abstract

Early cervical cancer, in particular in the presence of favorable pathologic risk factors, accounts for a very low incidence of parametrial involvement and lymph node metastasis. This means that a less radical surgery may be an oncologically safe treatment in selected cases, with the aim of preserving fertility and/or reducing morbidity without compromising survival. The extensiveness of surgery has decreased relatively in recent decades, the "modified" radical hysterectomy still being the current gold standard by most international guidelines. Vaginal (or abdominal) radical trachelectomy, simple hysterectomy, or cervical conization has been proposed in association with pelvic lymphadenectomy. Sentinel lymph node mapping may be an option to avoid a complete pelvic lymphadenectomy. Ongoing research efforts are especially being made in properly identifying the patient subset suitable for a conservative/less radical approach and prospectively confirming the oncological safety of the proposed clinical-pathological algorithms.

Entities:  

Mesh:

Year:  2012        PMID: 22945452     DOI: 10.1007/s11912-012-0269-1

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  53 in total

1.  Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study.

Authors:  Donald G Mitchell; Bradley Snyder; Fergus Coakley; Caroline Reinhold; Gillian Thomas; Marco Amendola; Lawrence H Schwartz; Paula Woodward; Harpreet Pannu; Hedvig Hricak
Journal:  J Clin Oncol       Date:  2006-12-20       Impact factor: 44.544

2.  Vaginal radical trachelectomy: an update.

Authors:  Marie Plante
Journal:  Gynecol Oncol       Date:  2008-08-27       Impact factor: 5.482

3.  Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study.

Authors:  P Benedetti-Panici; F Maneschi; G D'Andrea; G Cutillo; C Rabitti; M Congiu; F Coronetta; A Capelli
Journal:  Cancer       Date:  2000-05-15       Impact factor: 6.860

4.  ACR Appropriateness Criteria® pretreatment planning of invasive cancer of the cervix.

Authors:  Cary Lynn Siegel; Rochelle F Andreotti; Higinia Rosa Cardenes; Douglas L Brown; David K Gaffney; Neil S Horowitz; Marcia C Javitt; Susanna I Lee; Donald G Mitchell; David H Moore; Gautam G Rao; Henry D Royal; William Small; Mahesh A Varia; Catheryn M Yashar
Journal:  J Am Coll Radiol       Date:  2012-06       Impact factor: 5.532

5.  Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group.

Authors:  Christopher Altgassen; Hermann Hertel; Antje Brandstädt; Christhardt Köhler; Matthias Dürst; Achim Schneider
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

6.  Preoperative lymph-vascular space invasion is associated with nodal metastases in women with early-stage cervical cancer.

Authors:  Michael R Milam; Michael Frumovitz; Ricardo dos Reis; Russell R Broaddus; Roland L Bassett; Pedro T Ramirez
Journal:  Gynecol Oncol       Date:  2007-05-10       Impact factor: 5.482

7.  The risk of nodal metastasis in early adenocarcinoma of the uterine cervix.

Authors:  J Balega; H Michael; J Hurteau; D H Moore; J Santiesteban; G P Sutton; K Y Look
Journal:  Int J Gynecol Cancer       Date:  2004 Jan-Feb       Impact factor: 3.437

8.  Less radical surgery than radical hysterectomy in early stage cervical cancer: a pilot study.

Authors:  Marek Pluta; Lukas Rob; Martin Charvat; Roman Chmel; Michael Halaska; Petr Skapa; Helena Robova
Journal:  Gynecol Oncol       Date:  2009-03-04       Impact factor: 5.482

Review 9.  Surgery insight: radical vaginal trachelectomy as a method of fertility preservation for cervical cancer.

Authors:  Mario E Beiner; Allan Covens
Journal:  Nat Clin Pract Oncol       Date:  2007-06

10.  Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer.

Authors:  Michael Frumovitz; Charlotte C Sun; Kathleen M Schmeler; Michael T Deavers; Ricardo Dos Reis; Charles F Levenback; Pedro T Ramirez
Journal:  Obstet Gynecol       Date:  2009-07       Impact factor: 7.661

View more
  5 in total

1.  Is MRI helpful in assessing the distance of the tumour from the internal os in patients with cervical cancer below FIGO Stage IB2?

Authors:  P R Bhosale; R B Iyer; P Ramalingam; K M Schmeler; W Wei; R L Bassett; P T Ramirez; M Frumovitz
Journal:  Clin Radiol       Date:  2016-03-21       Impact factor: 2.350

2.  Aspects of Therapy for Cervical Cancer in Germany 2012 - Results from a Survey of German Gynaecological Hospitals.

Authors:  M Mangler; N Zech; A Schneider; C Köhler; S Marnitz
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-03       Impact factor: 2.915

3.  Accuracy of conization procedure for predicting pathological parameters of radical hysterectomy in stage Ia2-Ib1 (≤2 cm) cervical cancer.

Authors:  Huimin Bai; Dongyan Cao; Fang Yuan; Huilan Wang; Meizhu Xiao; Jie Chen; Quancai Cui; Keng Shen; Zhenyu Zhang
Journal:  Sci Rep       Date:  2016-05-16       Impact factor: 4.379

4.  Identification of a low risk population for parametrial invasion in patients with early-stage cervical cancer.

Authors:  Yohann Dabi; Claire Willecocq; Marcos Ballester; Xavier Carcopino; Sofiane Bendifallah; Lobna Ouldamer; Vincent Lavoue; Geoffroy Canlorbe; Emilie Raimond; Charles Coutant; Olivier Graesslin; Pierre Collinet; Alexandre Bricou; Cyrille Huchon; Emile Daraï; Bassam Haddad; Cyril Touboul
Journal:  J Transl Med       Date:  2018-06-14       Impact factor: 5.531

5.  Association of MRI-derived radiomic biomarker with disease-free survival in patients with early-stage cervical cancer.

Authors:  Jin Fang; Bin Zhang; Shuo Wang; Yan Jin; Fei Wang; Yingying Ding; Qiuying Chen; Liting Chen; Yueyue Li; Minmin Li; Zhuozhi Chen; Lizhi Liu; Zhenyu Liu; Jie Tian; Shuixing Zhang
Journal:  Theranostics       Date:  2020-01-16       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.